Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Rarebase Launches a Neuroscience Drug Discovery Platform Collaborating with 15 Rare Disease Patient Organizations
Rarebase, a public benefit biotechnology company, launched a tech-enabled drug discovery platform called Function. Function’s […]
Roche Opens Access to Pathology Imaging Tools to Improve Patient Care
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the introduction of the Roche Digital Pathology Open […]
Innovation and New Technology to Help Reduce NHS Waiting Lists
Local surgical hubs, new technology to speed up diagnosis, and innovative ways of working will […]
Cycle Pharmaceuticals Launches Cycle Vita ™, a Dedicated Support Platform for Rare Disease Patients
Cycle Pharmaceuticals (Cycle) is pleased to announce the launch of its Boston-based support platform for […]
Gloucestershire Hospitals NHS Foundation Trust Selects Hyland Healthcare for Enhanced Content Services Infrastructure
NHS Digital Aspirant Gloucestershire Hospitals NHS Foundation Trust (GHNHSFT) is moving a core element of its […]
Young People Aged 12 to 15 to be Offered a COVID-19 Vaccine
People aged 12 to 15 in England will be offered one dose of the Pfizer/BioNTech […]
Innova Medical Group Gifts £10m to Launch Global Pandemic Institute in Liverpool
Innova Medical Group, a global health innovator and the world’s largest provider of rapid antigen […]
Torbay and South Devon Selected for Pioneering Virtual HoloLens 2 Pilot
Torbay and South Devon NHS Foundation Trust (TSDFT), along with a small group of other […]
NHS Launches World’s Largest Trial of Cancer Blood Test
The NHS will today launch the world’s largest trial of a revolutionary new blood test […]
AbbVie and REGENXBIO Announce Eye Care Collaboration
AbbVie (NYSE: ABBV) and REGENXBIO Inc. (Nasdaq: RGNX) today announced a partnership to develop and […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more